Top Markets
#1 ADO Protocol ADO Protocol +233.73%
#2 Islamic Coin Islamic Coin +155.42%
#3 GoPlus Security GoPlus Security +60.87%
#4 Verus Coin Verus Coin +33.01%
#5 Starpower Starpower +28.54%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +16.10%
#8 o1.exchange o1.exchange +13.60%
#9 Status Status +11.71%
#10 Lumia Lumia +11.38%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rank in Stocks #33468
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Share Price
$0.5099
Last synced: 2024-10-15
Market Cap
$7.60M
Change (1 day)
2.02%
Change (1 year)
0.00%
Country
US
Trade Anew Medical, Inc. (WENA)

Category

Healthcare
P/B ratio for Anew Medical, Inc. (WENA)
P/B ratio as of August 2026 TTM: 0.63
According to Anew Medical, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0.63. At the end of 2022 the company had a P/B ratio of 0.79.
P/B ratio history for Anew Medical, Inc. from 2021 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 0.63 -87.86%
2023 5.20 561.31%
2022 0.79 -98.96%
2021 75.61 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 904.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 888.33%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 448.09%
BE